Tianxiang Jiang

ORCID: 0000-0002-7393-1207
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Biliary and Gastrointestinal Fistulas
  • Genetic factors in colorectal cancer
  • Gastrointestinal disorders and treatments
  • Gallbladder and Bile Duct Disorders
  • Gut microbiota and health
  • Inflammatory Bowel Disease
  • Intraperitoneal and Appendiceal Malignancies
  • Acupuncture Treatment Research Studies
  • Mycobacterium research and diagnosis
  • Esophageal and GI Pathology
  • Cancer Immunotherapy and Biomarkers
  • Epigenetics and DNA Methylation
  • Video Analysis and Summarization
  • Microscopic Colitis
  • Gastrointestinal Tumor Research and Treatment
  • Metastasis and carcinoma case studies
  • Human Pose and Action Recognition
  • Case Reports on Hematomas
  • Ferroptosis and cancer prognosis
  • Colorectal Cancer Surgical Treatments
  • Heat shock proteins research
  • FOXO transcription factor regulation
  • Multimodal Machine Learning Applications
  • Sarcoma Diagnosis and Treatment

Sichuan University
2022-2025

Zhejiang Chinese Medical University
2024-2025

Wenzhou Medical University
2025

Dalian University
2025

Yuncheng University
2025

West China Hospital of Sichuan University
2023-2024

South China Normal University
2024

We introduce InternVideo2, a new video foundation model (ViFM) that achieves the state-of-the-art performance in action recognition, video-text tasks, and video-centric dialogue. Our approach employs progressive training paradigm unifies different self- or weakly-supervised learning frameworks of masked token reconstruction, cross-modal contrastive learning, next prediction. Different stages would guide our to capture levels structure semantic information through pretext tasks. At data...

10.48550/arxiv.2403.15377 preprint EN arXiv (Cornell University) 2024-03-22

Abstract Intratumor bacteria, a critical component of the tumor microenvironment, can facilitate growth and contribute to development resistance chemotherapeutic agents. The agents not only induce protective autophagy in tumors, contributing drug resistance, but also exert minimal effects on bacteria within tumor, thereby potentially accelerating recurrence. To address this tough issue, vermiculite/copper telluride bio‐heterojunctions (VIC bio‐HJs) have been developed enhance eradicate...

10.1002/adfm.202421288 article EN Advanced Functional Materials 2025-01-16

Abstract Background In cancer patients receiving immune checkpoint inhibitors (ICIs), there is emerging evidence suggesting a correlation between gut microbiota and immune-related adverse events (irAEs). However, the exact roles of causal associations are yet to be clarified. Methods To investigate this, we first conducted univariable bi-directional two-sample Mendelian randomization (MR) analysis. Instrumental variables (IVs) for were retrieved from MiBioGen consortium (18,340...

10.1186/s40001-024-01741-7 article EN cc-by European journal of medical research 2024-03-12

Nucleosome assembly during DNA replication is dependent on histone chaperones. Recent studies suggest that dysregulated chaperones contribute to cancer progression, including gastric (GC). Further are required explore the prognostic and therapeutic implications of their mechanisms action in GC progression. Here we identified chaperone ASF1B as a potential biomarker for proliferation prognosis. was significantly upregulated GC, which associated with poor In vitro vivo experiments demonstrated...

10.1016/j.canlet.2024.216796 article EN cc-by-nc-nd Cancer Letters 2024-03-26

Hepatic hemangioma is among the most common benign liver lesions. However, giant pedunculated hepatic hemangiomas are exceptionally rare and associated with additional risks, such as torsion.We present case of a 63-year-old female patient who presented abdominal distension pain. Barium meal examination gastroscopy revealed large, smooth-surfaced submucosal bulge located at fundus stomach. Subsequent MRI identified mass measuring approximately 6.4 x 7 cm in left upper abdomen. Surgical...

10.3389/fonc.2023.1165195 article EN cc-by Frontiers in Oncology 2023-07-31

Objectives: Assess the prevalence, mortality, and disability-adjusted life years (DALYs) of vascular intestinal disorders (VID) from 1990 to 2019. Methods: This study conducted a secondary data analysis utilizing Global Burden Diseases Study The mortality DALYs VID were analyzed by sex, age socio-demographic index (SDI), respectively. Analyses performed using R software. Results: Globally, number prevalent cases increased 100,158 (95% uncertainty interval: 89,428-114,013) in 1,990-175,740...

10.3389/ijph.2023.1606297 article EN cc-by International Journal of Public Health 2023-09-26

Paclitaxel (PTX) cannot effectively treat glioma because it cross the bloodbrain barrier (BBB). A specific mode electroacupuncture stimulation (SMES) can temporarily open BBB, thereby improving drug delivery to brain. This study aimed observe SMES-mediated accumulation of PTX in brain and its anti-glioma effect explore role Hedgehog pathway.

10.1016/j.brainresbull.2024.110985 article EN cc-by-nc-nd Brain Research Bulletin 2024-05-26

Abstract Cognitive impairment frequently presents as a prevalent consequence following stroke, imposing significant burdens on patients, families, and society. The objective of this study was to assess the effectiveness underlying mechanism nerve growth factor (NGF) in treating post-stroke cognitive dysfunction rats with cerebral ischemia–reperfusion injury (MCAO/R) through delivery into brain using specific mode electroacupuncture stimulation (SMES). From 28th day after modeling, were...

10.1007/s12035-024-04337-8 article EN cc-by Molecular Neurobiology 2024-07-12

Background Crohn’s disease (CD) is a chronic inflammatory condition primarily affecting the digestive system. When dealing with complex cases like intestinal blockages or perforations, surgery becomes primary treatment option. However, doesn’t offer complete cure, and possibility of recurrence remains. To manage CD after surgery, various choices are available, including steroids, monoclonal antibodies, immunomodulators, further surgery. Regrettably, current body evidence definitively...

10.1371/journal.pone.0310752 article EN cc-by PLoS ONE 2024-10-09

Abstract Background In cancer patients receiving immune checkpoint inhibitors (ICIs), there is emerging evidence suggesting a correlation between gut microbiota and immune-related adverse events (irAEs). However, the exact roles of causal associations are yet to be clarified. Methods To investigate this, we first conducted univariable bi-directional two-sample Mendelian randomization (MR) analysis. Instrumental variables (IVs) for were retrieved from MiBioGen consortium (18,340...

10.1101/2023.07.24.23292742 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2023-07-27
Coming Soon ...